| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-05 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-05 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |